№ lp_1_2_13739
File format: docx
Character count: 26565
File size: 79 KB
This document evaluates the national implementation of quality improvement activities focusing on medication safety and adverse drug event (ADE) prevention by the Quality Innovation Network Quality Improvement Organizations (QIN-QIOs).
Note:
Year
Theme:
Healthcare, Medication Safety, Adverse Drug Event Prevention
Document Type:
Program Evaluation Report
Organization / Institution:
Centers for Medicare & Medicaid Services (CMS)
Target Audience:
Healthcare Providers, Medicare Beneficiaries, Policymakers
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / city:
Bonn, Germany
Topic:
Ecological connectivity, CMS Article III.4
Document type:
Workshop preparatory material
Organization:
UNEP, CMS
Target audience:
Workshop participants, national legislators, conservation experts
Period of validity:
3–5 June 2025
Date of approval:
20 May 2025
Date of amendments:
N/A
Year:
July 2022
Note:
Region / City
Document Type:
Validation Checklist
Contextual description:
A validation checklist for medicinal product applications within the Decentralized Procedure (DCP) process.
Year:
Not specified
Region / City:
Not specified
Topic:
Business Continuity, Risk Management
Document Type:
Procedure
Organization / Institution:
Centers for Medicare & Medicaid Services (CMS)
Author:
Not specified
Target Audience:
Business Owners, CMS Stakeholders
Effective Period:
Every two years
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2019
Region / City:
Baltimore, Maryland
Topic:
Information Security, Network Interconnection
Document Type:
Agreement
Organization:
Centers for Medicare & Medicaid Services (CMS)
Author:
Centers for Medicare & Medicaid Services (CMS)
Target Audience:
Non-CMS Organizations, CMS IT and Security Personnel
Period of Action:
Ongoing
Approval Date:
August 9, 2019
Amendment Date:
Not specified
Year:
2022
Region / City:
United States
Theme:
Medicare Advantage, Prescription Drug Plan, Health Policy
Document Type:
Report
Institution / Organization:
Centers for Medicare & Medicaid Services (CMS)
Author:
Centers for Medicare & Medicaid Services (CMS)
Target Audience:
Medicare Advantage and Prescription Drug Plan organizations, healthcare administrators, policy makers
Period of Validity:
CY 2022
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2018
Note:
Region / City
Topic:
Call Management System (CMS) Software Release Notes
Document Type:
Release Notes
Organization / Institution:
Avaya
Target Audience:
System administrators, IT professionals, and support teams managing CMS R17
Period of validity:
May 14, 2018 and onwards
Approval Date:
May 14, 2018
Year:
2018
Region / city:
United States
Subject:
Medicare Advantage, Prescription Drug Plan, Medicare
Document Type:
Supporting Statement
Organization / institution:
Centers for Medicare & Medicaid Services (CMS)
Author:
Centers for Medicare & Medicaid Services (CMS)
Target Audience:
Medicare Advantage (MA) and Prescription Drug Plan (PDP) organizations
Period of validity:
CY 2018 through CY 2019
Approval Date:
Not specified
Date of amendments:
Not specified
Year:
2019
Region / City:
United States
Topic:
Privacy Act, HIPAA, FISMA, Data Use Agreement
Document Type:
Regulatory Form
Agency/Institution:
Centers for Medicare & Medicaid Services (CMS)
Author:
Not specified
Target Audience:
Researchers, federal and state agencies, CMS contractors
Effective Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2020
Region / City:
United States
Topic:
Healthcare, Medicare, Drug Pricing
Document Type:
Instruction Sheet
Agency / Institution:
Centers for Medicare & Medicaid Services (CMS)
Author:
CMS
Target Audience:
Hospitals participating in the 340B Program
Effective Period:
April 2020 - May 15, 2020
Approval Date:
N/A
Amendment Date:
N/A
Confidentiality:
Yes
Year:
2026
Region / City:
Massachusetts
Topic:
Healthcare Policy
Document Type:
Bulletin
Agency / Organization:
Executive Office of Health and Human Services, Office of Medicaid
Author:
Mike Levine, Undersecretary for MassHealth
Target Audience:
Nursing Facilities Participating in MassHealth
Effective Date:
January 26, 2026
Date of Approval:
January 2026
Date of Amendments:
N/A
Description:
A bulletin explaining updates to the transition from MMQ policies to CMS OBRA MDS 3.0 assessments for determining nursing facility payments under MassHealth.
Year:
2025
Region / city:
Bonn, Germany
Topic:
Flyways, Migratory Birds, CMS
Document Type:
Draft Programme of Work
Organization / Institution:
CMS Scientific Council
Author:
CMS Secretariat
Target audience:
CMS members, Scientific Council, Flyways Working Group
Period of validity:
2026-2029
Approval date:
To be approved at ScC-SC8
Date of revisions:
None
Year:
2025
Region / City:
Latin America
Topic:
Human-Wildlife Conflict, Jaguar Conservation
Document Type:
Report
Organization / Institution:
IUCN SSC Human-Wildlife Conflict & Coexistence Specialist Group
Author:
Alexandra Zimmermann, Luna Milatovic
Target Audience:
Conservation professionals, policymakers, wildlife experts
Period of validity:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A
Year:
2025
Event:
Global Workshop on CMS Legislation
Location:
Bonn, Germany
Dates:
3–5 June 2025
Session:
Session 3
Document reference:
UNEP/CMS/GWL/Doc.4
Issuing body:
CMS Secretariat
Legal framework:
Convention on the Conservation of Migratory Species of Wild Animals
Article addressed:
CMS Article III.5
Subject matter:
National implementation of the prohibition on taking of Appendix I species
Document type:
Workshop preparatory and facilitation material
Target audience:
National authorities and participants in the National Legislation Programme
Preparation date:
5 May 2025
Year:
2024
Region / City:
Samarkand
Topic:
Migratory species conservation, CMS decisions
Document Type:
Conference decisions
Organization:
CMS
Author:
Conference of the Parties to CMS
Target Audience:
Parties to the CMS
Period of Validity:
2024-2032
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2021
Region / City:
Online
Topic:
Biodiversity, Migratory Species Conservation
Document Type:
Report
Institution:
UNEP/CMS
Author:
Not specified
Target Audience:
Not specified
Period of Action:
2021
Approval Date:
21-29 September 2021
Date of Changes:
Not specified
Year:
2019
Region / city:
OECD
Topic:
Adverse Outcome Pathway, oxidative stress, brain development, neurotoxicity
Document Type:
External Review Report
Author:
OECD EAGMST review manager
Target Audience:
Scientific community, regulators, policymakers
Period of validity:
Not specified
Approval Date:
June 2018
Date of revisions:
17 March 2020
Year:
2024
Region / city:
UK
Topic:
Climate change, extreme weather, workplace safety
Document type:
Policy document
Organization / institution:
UNISON, TUC
Author:
UNISON
Target audience:
Trade union representatives, employers, workers
Period of validity:
2024–2025
Approval date:
Not specified
Date of changes:
Not specified
Note:
Year
Year:
2003
Region / City:
Mount Sinai Hospital
Subject:
Clinical Research
Document Type:
Guideline
Organization / Institution:
Mount Sinai Hospital REB
Author:
REB Chair
Target Audience:
Clinical Investigators, Research Staff
Effective Period:
Ongoing
Approval Date:
November 6, 2003
Revision Date:
July 8, 2015
Year:
2026
Region / City:
Boston, MA
Topic:
Clinical Research, Adverse Event Reporting
Document Type:
Form
Author:
BU Medical Campus
Target Audience:
Clinical research staff
Period of validity:
Ongoing
Approval Date:
2026-01-01
Date of Changes:
Not specified